866-997-4948(US-Canada Toll Free)

Brain Tumor Diagnosis and Treatments Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency

Published Date : Aug 2017

Category :

In Vitro Diagnostics

No. of Pages : 160 Pages

Global Brain Tumor Diagnosis and Treatments Market: Overview

This report on brain tumor diagnosis and treatments market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of brain tumor diagnosis and treatments as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global brain tumor diagnosis and treatments market with respect to the leading market segments based on major products type segment, diagnosis type, treatment type and geographies.

Global Brain Tumor Diagnosis and Treatments Market: Segmentation

Based on the product type, the brain tumor diagnosis and treatments market has been segmented into: primary brain tumors (meningioma, gliomas, astrocytomas, pituitary tumors and others) and secondary brain tumors. Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of brain tumors incidences worldwide, technological advancement, and growing number of use of brain tumor diagnosis and treatments  in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Brain Tumor Diagnosis and Treatments Market: Key Research Aspects

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the brain tumor diagnosis and treatments market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global Brain Tumor Diagnosis and Treatments market.

Geographically, brain tumor diagnosis and treatments market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global brain tumor diagnosis and treatments market.

Global Brain Tumor Diagnosis and Treatments Market: Competitive Landscape

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global brain tumor diagnosis and treatments market.

The report also profiles key players operating in the brain tumor diagnosis and treatments market which are AstraZeneca, Carestream Health, GE Healthcare, Hitachi Medical Corporation, Merck & Co., Inc., Philips Healthcare, Pfizer, Inc., Shimadzu Corporation, Siemens Healthineers, Toshiba Medical Systems Corporation and other prominent players.

The global brain tumor diagnosis and treatments market is segmented as follows:

Brain Tumor Diagnosis and Treatments Market, by Product Type

  • Primary Brain Tumor
  • Meningioma
  • Gliomas
  • Astrocytomas
  • Pituitary Tumors
  • Others
  • Secondary Brain Tumor

Brain Tumor Diagnosis and Treatments Market, by Diagnosis Type

  • CT Scan
  • MRI
  • PET-CT Scan
  • Molecular Testing
  • EEG
  • Others

Brain Tumor Diagnosis and Treatments Market, by Treatment Type

  • Surgery
  • Radiation Therapy
  • Targeted Therapy
  • Chemotherapy
  • Immunotherapy

Brain Tumor Diagnosis and Treatments Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • U.K.
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Brain Tumor Diagnosis and Treatment Market

4. Market Overview
4.1. Introduction
4.1.1. Product Overview
4.1.2. Key Industry Events
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Porter’s Five Forces Analysis
4.4. Value Chain Analysis
4.5. Market Outlook

5. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Product Type
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Market Value Forecast By Product Type , 2017-2025
5.3.1. Primary Brain Tumor
5.3.1.1. Meningioma
5.3.1.2. Gliomas
5.3.1.3. Astrocytomas
5.3.1.4. Pituitary Tumors
5.3.1.5. Others
5.3.2. Secondary Brain Tumor
5.4. Key Trends
5.5. Market Attractiveness By Product Type

6. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Diagnosis Type
6.1. Key Findings / Developments
6.2. Introduction & Definition
6.3. Market Value Forecast By Diagnosis Type, 2017–2025
6.3.1. CT Scan
6.3.2. MRI
6.3.3. PET-CT Scan
6.3.4. Molecular Testing
6.3.5. EEG
6.3.6. Others
6.4. Key Trends
6.5. Market Attractiveness By Diagnosis Type

7. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, By Treatment Type
7.1. Key Findings / Developments
7.2. Introduction & Definition
7.3. Market Value Forecast By Treatment Type, 2017–2025
7.3.1. Surgery
7.3.2. Radiation Therapy
7.3.3. Targeted Therapy
7.3.4. Chemotherapy
7.3.5. Immunotherapy
7.4. Key Trends
7.5. Market Attractiveness By Diagnosis Type

8. Global Brain Tumor Diagnosis and Treatments Market Analysis and Forecasts, by Region
8.1. Policies and Regulations
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis By Region

9. North America Brain Tumor Diagnosis and Treatments Market Analysis and Forecast
9.1. Market Value Forecast By Country, 2017-2025
9.1.1. U.S.
9.1.2. Canada
9.2. Market Value Forecast By Product Type
9.3. Market Value Forecast By Diagnosis Type
9.4. Market Value Forecast By Treatment Type
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Product Type
9.5.3. By Diagnosis Type
9.5.4. By Treatment Type

10. Europe Brain Tumor Diagnosis and Treatments Analysis and Forecast
10.1. Market Value Forecast By Country, 2017-2025
10.1.1. Germany
10.1.2. Spain
10.1.3. France
10.1.4. U.K.
10.1.5. Italy
10.1.6. Rest of Europe
10.2. Market Value Forecast By Product Type
10.3. Market Value Forecast By Diagnosis Type
10.4. Market Value Forecast By Treatment Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Diagnosis Type
10.5.4. By Treatment Type

11. Asia Pacific Brain Tumor Diagnosis and Treatments Analysis and Forecast
11.1. Market Value Forecast By Country, 2017-2025
11.1.1. China
11.1.2. India
11.1.3. Japan
11.1.4. Rest of Asia Pacific
11.2. Market Value Forecast By Product Type
11.3. Market Value Forecast By Diagnosis Type
11.4. Market Value Forecast By Treatment Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Diagnosis Type
11.5.4. By Treatment Type

12. Latin America Brain Tumor Diagnosis and Treatments Analysis and Forecast
12.1. Market Value Forecast By Country, 2017-2025
12.1.1. Brazil
12.1.2. Mexico
12.1.3. Rest of Latin America
12.2. Market Value Forecast By Product Type
12.3. Market Value Forecast By Diagnosis Type
12.4. Market Value Forecast By Treatment Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Diagnosis Type
12.5.4. By Treatment Type

13. Middle East and Africa Brain Tumor Diagnosis and Treatments Analysis and Forecast
13.1. Market Value Forecast By Country, 2017-2025
13.1.1. South Africa
13.1.2. Saudi Arabia
13.1.3. Rest of Middle East and Africa
13.2. Market Value Forecast By Product Type
13.3. Market Value Forecast By Diagnosis Type
13.4. Market Value Forecast By Treatment Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Diagnosis Type
13.5.4. By Treatment Type

14. Competition Landscape
14.1. Heat Map Analysis By Company (2016)
14.2. Competition Matrix
14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy )
14.3.1. AstraZeneca
14.3.1.1. Company Details
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.1.6. Recent Development
14.3.2. Carestream Health
14.3.2.1. Company Details
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.2.6. Recent Development
14.3.3. GE Healthcare
14.3.3.1. Company Details
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.3.6. Recent Development
14.3.4. Hitachi Medical Corporation
14.3.4.1. Company Details
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.4.6. Recent Development
14.3.5. Merck & Co., Inc.
14.3.5.1. Company Details
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.5.6. Recent Development
14.3.6. Philips Healthcare
14.3.6.1. Company Details
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.6.6. Recent Development
14.3.7. Pfizer, Inc.
14.3.7.1. Company Details
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.7.6. Recent Development
14.3.8. Shimadzu Corporation
14.3.8.1. Company Details
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.8.6. Recent Development
14.3.9. Siemens Healthineers
14.3.9.1. Company Details
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis
14.3.9.6. Recent Development
14.3.10. Toshiba Medical System Corporation
14.3.10.1. Company Details
14.3.10.2. Business Overview
14.3.10.3. Financial Overview
14.3.10.4. Strategic Overview
14.3.10.5. SWOT Analysis
14.3.10.6. Recent Development

List of Table

TABLE 1 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 2 Global Primary Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 3 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 4 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 5 Global Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2025
TABLE 6 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 7 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 8 North America Primary Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Product Type, 2017–2025
TABLE 9 North America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Diagnosis Type, 2017–2025
TABLE 10 North America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Treatment Type, 2017–2025
TABLE 11 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 12 Europe Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 13 Europe Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 14 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 15 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 16 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 17 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 18 Asia Pacific Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 19 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 20 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 21 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 22 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 23 Latin America Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 24 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 25 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025
TABLE 26 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Country, 2017–2025
TABLE 27 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 28 Middle East & Africa Primary Brain Tumor Diagnosis and Treatment Market Size (US$) Forecast, by Product Type, 2017–2025
TABLE 29 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Diagnosis Type, 2017–2025
TABLE 30 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017–2025

List of Chart

FIG. 1 Global Brain Tumor Diagnosis and Therapeutics Market Size (US$ Mn) and Forecast, 2016–2025
FIG. 2 Brain Tumor Diagnosis and Treatment Market Value share, by Product Type (2016)
FIG. 3 Brain Tumor Diagnosis and Treatment Market Value share, by Diagnosis Type (2016)
FIG. 4 Brain Tumor Diagnosis and Treatment Market Value share, by Treatment Type (2016)
FIG. 5 Brain Tumor Diagnosis and Treatment Market Value share, by Region (2016)
FIG. 6 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Product Type, 2016 and 2025
FIG. 7 Global Primary Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Product Type, 2016 and 2025
FIG. 8 Global Primary Brain Tumor Diagnosis and Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
FIG. 9 Global Secondary Brain Tumor Diagnosis and Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2025
FIG. 10 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 11 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Diagnosis Type, 2016 and 2025
FIG. 12 Global CT Scan Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 13 Global MRI Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 14 Global PET-CT Scan Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 15 Global Molecular Testing Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 16 Global EEG Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 17 Global Others Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 18 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 19 Global Brain Tumor Diagnosis and Treatment Market Value Share Analysis, by Treatment Type, 2016 and 2025
FIG. 20 Global Surgery Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 21 Global Radiation Therapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 22 Global Targeted Therapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 23 Global Chemotherapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2025
FIG. 24 Global Immunotherapy Brain Tumor Diagnosis and Treatment Market Value (US$ Mn) and Y-o-Y Growth (%), 2017-2025
FIG. 25 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 26 North America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 27 Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 28 Asia Pacific Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 29 Latin America Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 30 MEA Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 31 Global Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Region
FIG. 32 U.S. Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 33 Canada Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 34 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 35 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 36 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 37 North America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 38 Germany Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 39 Spain Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 40 France Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 41 U.K. Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 42 Italy Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 43 Rest of Europe Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 44 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 45 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 46 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 47 Europe Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 48 China Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 49 India Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 50 Japan Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 51 Rest of APAC Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 52 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 53 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 54 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 55 Asia Pacific Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 56 Brazil Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 57 Mexico Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 58 Rest of LATAM Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 59 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 60 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 61 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 62 Latin America Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Treatment Type
FIG. 63 South Africa Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 64 Saudi Arabia Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 65 Rest of MEA Brain Tumor Diagnosis and Treatment Market Size (US$ Mn) Forecast, 2017–2025
FIG. 66 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Country
FIG. 67 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Product Type
FIG. 68 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 69 Middle East & Africa Brain Tumor Diagnosis and Treatment Market Attractiveness Analysis, by Diagnosis Type
FIG. 70 Figure 70: Heat Map Analysis By Company (2016)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *